Redwood Pharma AB announced earnings results for the fourth quarter and year ended December 31, 2020. For the quarter, Operating loss was SEK 4.310 million compared to SEK 3.833 million a year ago. Net loss was SEK 4.310 million compared to SEK 3.833 million a year ago. Loss per share for the period was SEK 0.28 against SEK 0.30 a year ago. For the full year, the company announced operating loss was SEK 14.522 million compared to SEK 15.512 million a year ago. Net loss was SEK 14.525 million compared to SEK 15.757 million a year ago. Loss per share for the period was SEK 0.97 against SEK 1.07 a year ago.